JavaScript is disabled for your browser. Some features of this site may not work without it.
dc.contributor.author
Beka, Eleni
en
dc.date.accessioned
2017-04-03T06:56:01Z
dc.date.available
2017-04-04T00:00:20Z
dc.date.issued
2017-04-03
dc.identifier.uri
https://repository.ihu.edu.gr//xmlui/handle/11544/15221
dc.rights
Default License
dc.subject
Pharmaceutical Patents
en
dc.title
Patent Law and the Pharmaceutical Industry
en
heal.type
masterThesis
el
heal.classification
Law
en
heal.keywordURI.LCSH
Patent laws and legislation
heal.keywordURI.LCSH
Pharmaceutical industry--Law and legislation
heal.language
en
el
heal.access
free
el
heal.license
http://creativecommons.org/licenses/by-nc/4.0
el
heal.recordProvider
School of Economics, Business Administration and Legal Studies, MA in Art, Law and Economy
el
heal.publicationDate
2017-01-22
heal.bibliographicCitation
Beka, Patent Law and the Pharmaceutical Industry, School of Economics, Business Administration and Legal Studies, International Hellenic University, 2017.
en
heal.abstract
This dissertation was written as part of the MA in Art, Law and Economy at the International Hellenic University. In this dissertation, there will be an analysis of pharmaceutical patents and some issues that are created due to their existence. In the first chapter, there will be an analy- sis of what is medicine, which are its types and especially an analysis of generics, since they play a major role in in the pharmaceutical industry. In the second chapter, there will be an analysis of the types of pharmaceutical patents and the special certificate for pharmaceuticals, the supplementary protection certificate. Moreover, the economical and technological use of pharmaceutical patents will also be discussed. The interaction of archetypes and generics in the pharmaceutical industry affects this industry through aspects such as competition, parallel import, licenses and access to medicines, issues that will be discussed in the third and fourth chapter. Some case study will be provided concerning not only these issues, but also other great issues, such as the AstraZeneca case, that have affected the pharmaceutical industry. Finally, some conclusions that were made after this research will be provided in the last chapter.
Keywords: competition, generics, medicines, patent, pharmaceutical.
Eleni Beka 22 January 2017
en
heal.advisorName
Chrissanthis, Christos
en
heal.committeeMemberName
Kaissis, Athanassios
en
heal.committeeMemberName
Komnios, Komninos
en
heal.academicPublisher
IHU
en
heal.academicPublisherID
ihu
el
heal.numberOfPages
56
el
This item appears in the following Collection(s)
Related Items
Browse
-
All of IHU Repository
-
This Collection
My Account
Statistics
©International Hellenic University.
